Physician profile
Jon Harris
NPI 1598109035
$1,073.64
in general payments reported to CMS, 2019-2025
15 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $122 · 2021: $165 · 2022: $33.42 · 2023: $107 · 2024: $17.12 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $535.82 | 2019-2022 | |
| Davol INC. | $165.37 | 2020-2023 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $65.88 | 2019-2025 | Exparel |
| Integra Lifesciences Corporation | $53.55 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Braintree Laboratories, INC. | $44.99 | 2020-2021 | |
| Ethicon US, LLC | $42.11 | 2019-2025 | Proximate |
| Medtronic, INC. | $39.69 | 2023-2025 | Het, Transorb |
| Allergan, INC. | $22.57 | 2019 | |
| Mimedx Group, INC. | $17.12 | 2024 | |
| Solventum Corporation | $16.52 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Novo Nordisk INC | $14.87 | 2023 | Wegovy |
| Kci USA, INC. | $14.50 | 2023 | Snap, Prevena, V.A.C. Dermatac |
| Tela Bio, INC. | $14.43 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Endo Pharmaceuticals INC. | $13.92 | 2022 | |
| Minerva Surgical, INC | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.